DOI: 10.14704/nq.2019.17.5.2271

Inherited Real Risk of Schizophrenia: Pathogenesis, Bedside Diagnosis and Primary Prevention

Marco Marchionni, Simone Caramel, Sergio Stagnaro

Abstract


The comprehension of the pathogenesis of schizophrenia finds a new impulse in studies on non- linear dynamics of EEG signals and in the growing genetic molecular evidence of the mitochondrial origin of this disease. These data are consistent with the information known by Quantum Biophysical Semeiotics, that clinically investigates microcirculation both on a functional (i.e. by studying its non-linear dynamics), and on a structural viewpoint.

Mitochondrial and microcirculatory dysfunctions reflect those of a genetically altered mit-DNA and of a functional mitochondrial cytopathy known as Congenital Acidosic Enzyme-Metabolic Histangiopathy, originating from this mutation and which is particularly intense both in patients with schizophrenia and in those with Inherited Real Risk of this disorder.
Preclinical diagnosis of Inherited Real Risk of schizophrenia presents the opportunity to examine subjects with a predisposition to this disease since birth, in order to perform an efficient pre- primary and primary prevention.

Keywords


schizophrenia diagnosis, mitochondrial dysfunction, primary prevention, quantum therapy, deterministic chaos

Full Text:

PDF

References


Akar SA, Kara S, Latifoğlu F, Bilgiç V. Analysis of the Complexity Measures in the EEG of Schizophrenia Patients. Int J Neural Syst 2016; (2): 1650008.

Al-Awee IC, Krishnamurthy KB, Hausdorff JM, Mietus JE, Ives JR, Blum AS, Schomer DL, Goldberger AL. Postictal heart rate oscillations in partial epilepsy. Neurology 1999; 53(7): 1590-1592.

Bär KJ, Boettger MK, Koschke M, Schulz S, Chokka P, Yeragani VK, Voss A. Non-linear complexity measures of heart rate variability in acute schizophrenia. Clin Neurophysiol 2007; 118(9):2009-2015.

Bär KJ, Koschke M, Berger S, Schulz S, Tancer M, Voss A, Yeragani VK. Influence of olanzapine on QT variability and complexity measures of heart rate in patients with schizophrenia. J Clin Psychopharmacol 2008; 28(6): 694-698.

Benarous X and Cohen D. To err is human? Interests of chaotic models to study adult psychiatric disorders and developmental disorders. Encephale 2016; 42(1):82-89.

Bullmore E, Brammer M, Harvey I, Persaud R, Murray R, Ron M. Fractal analysis of the boundary between white matter and cerebral cortex in magnetic resonance images: a controlled study of schizophrenic and manic-depressive patients. Psychol Med 1994; 24(3): 771-781.

Clay H, Sillivan S, Konradi C. Mitochondrial Dysfunction and Pathology in Bipolar Disorder and Schizophrenia. Int J Dev Neurosci 2011; 29(3): 311–324.

Fernández A, Gómez C, Hornero R, López-Ibor JJ. Complexity and schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2013; 45: 267-276.

Ha TH, Yoon U, Lee KJ, Shin YW, Lee JM, Kim IY, Ha KS, Kim SI, Kwon JS. Fractal dimension of cerebral cortical surface in schizophrenia and obsessive-compulsive disorder. Neurosci Lett 2005; 384(1-2): 172-176.

Hjelm BE, Rollins B, Mamdani F, Lauterborn JC, Kirov G, Lynch G, Gall CM , Sequeira A, Vawter MP. Evidence of Mitochondrial Dysfunction within the Complex Genetic Etiology of Schizophrenia. Mol Neuropsychiatry 2015;1(4): 201-219.

Huberman BA. A model for dysfunctions in smooth pursuit eye movement. Ann N Y Acad Sci 1987; 504: 260-273.

Keshavan MS, Cashmere JD, Miewald J, Yeragani VK. Decreased nonlinear complexity and chaos during sleep in first episode schizophrenia: a preliminary report. Schizophr Res 2004; 71(2-3): 263-272.

Kleszczewski T, Rutkiewicz W. The fractal box dimension on human eyeball movement-- objective, biological marker ofschizophrenia? Eur Psychiatry 2004; 19(8): 514-515.

Korsakova et al. Diagnosis of different stages of epileptogenesis by fractal EEG analysis. Zh Nevrol Psikhiatr Im S S Korsakova 2011; 111(5): 37-41.

Lee KH , Williams LM, Loughland CM, Davidson DJ, Gordon E. Syndromes of schizophrenia and smooth-pursuit eye movement dysfunction. Psychiatry Res 2001;101(1): 11-21.

Manatt M, Chandra SB. The effects of mitochondrial dysfunction in schizophrenia. Journal of Medical Genetics and Genomics 2011; 3(5): 84-94.

Owen MJ, Sawa A , Mortensen PB. Schizophrenia. Lancet 2016; 388(10039): 86-97.

Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JTJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Molecular Psychiatry 2004; 9: 684–697.

Raghavendra BS, Dutt DN, Halahalli HN, John JP. Complexity analysis of EEG in patients with schizophrenia using fractal dimension. Physiol Meas 2009; 30(8): 795-808.

Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev 2015; 48: 10-21.

Sabeti M, Katebi S, Boostani R. Entropy and complexity measures for EEG signal classification of schizophrenic and control participants. Artif Intell Med 2009; 47(3): 263-274.

Sandu AL, Rasmussen IA Jr, Lundervold A, Kreuder F, Neckelmann G, Hugdahl K, Specht K. Fractal dimension analysis of MR images reveals grey matter structure irregularities in schizophrenia. Comput Med Imaging Graph 2008; 32(2): 150-158.

Scaglia F. The Role of Mitochondrial Dysfunction In psychiatric Disease Developmental Disabilities Research Reviews 2010; 16: 136–143.

Schmiedel J, Jackson S, Schäfer J, Reichmann H. Mitochondrial cytopathies. Journal of neurology 2003; 250(3): 267-277.

Silverstein SM, Rosen R. Schizophrenia and the eye. Schizophrenia Research: Cognition. 2015; 2(2): 46-55.

Squarcina L, De Luca A, Bellani M, Brambilla P, Turkheimer FE, Bertoldo A. Fractal analysis of MRI data for the characterization of patients with schizophrenia and bipolar disorder. Phys Med Biol 2015; 60(4): 1697-1716.

Stagnaro S. Auscultatory percussion of the cerebral tumour: diagnostic importance of the evoked potentials. Biol. Med 1985a; 7: 171–175.

Stagnaro S. Percussione ascoltata degli attacchi ischemici transitori. Ruolo dei Potenziali Cerebrali Evocati. Min Med 1985b; 76: 1211.

Stagnaro S. “Valutazione percusso-ascoltatoria della microcircolazione cerebrale globale e regionale,” in Atti, XII Congr. Naz. Soc. It. di Microangiologia e Microcircolazione, e Acta Medit 1986; 145: 163.

Stagnaro S. Inherited real risk of brain disorders. PLoS ONE 2009a.

http://www.plosone.org/article/comments/info%3Adoi%2F10.1371%2Fjournal.pone.0006354

Stagnaro S. Pre-metabolic syndrome and metabolic syndrome: biophysical-semeiotic viewpoint. Atheroscler Soc 2009b. http://www.athero.org/commentaries/comm904.asp

Stagnaro S. Reale Rischio Semeiotico Biofisico. I Dispositivi Endoarteriolari di Blocco Neoformati, Patologici, Tipo I, Sottotipo a) Oncologico, e b) Aspecifico. Travel Factory, Roma, 2009c.

Stagnaro S and Caramel S. Clinical QBS diagnosis and primary prevention of brain disorder ‘Inherited Real Risk’ and Alzheimer disease. J. Quantum Biophys. Semeiot 2011. http://www.sisbq.org/uploads/5/6/8/7/5687930/alzheimer_primaryprevention.pdf

Stagnaro S and Caramel S. Vascular calcification and inherited real risk of lithiasis. Front Endocrinol 2012; 3: 119.

Stagnaro S and Caramel S. Inherited real risk of type 2 diabetes mellitus: bedside diagnosis, pathophysiology and primary prevention. Front Endocrinol 2013a; 4: 17.

Stagnaro S and Caramel S. The inherited real risk of coronary artery disease. Eur J Clin Nutr Nature PG, 2013b.

Stagnaro S and Caramel S. The role of modified mediterranean diet and quantum therapy in oncological primary prevention. Curr Nutr Food Sci 2013c; 9: 65–72.

Stagnaro S and Caramel S. The role of modified mediterranean diet and quantum therapy in type 2 diabetes mellitus primary prevention. J Pharm Nutr Sci 2013d; 3: 59–70.

Stagnaro S and Stagnaro-Neri M. “Il test della Apnea nella Valutazione della Microcircolazione cerebrale in Cefalalgici,” in Atti Congr Naz Soc Ita Microangiologia e Microcircolazione 1987. A cura di C. Allegra. Ed Monduzzi, Bologna, 457.

Stagnaro S and Stagnaro-Neri M. Le Costituzioni Semeiotico Biofisiche. Strumento clinico fondamentale per la prevenzione primaria e la definizione della Single Patient Based Medicine. Ed Travel Factory, Roma, 2004a.

Stagnaro S and Stagnaro-Neri M. Introduzione alla Semeiotica Biofisica. Il Terreno oncologico. Ed Travel Factory SRL, Roma, 2004b.

Stagnaro-Neri M and Stagnaro S. “Auscultatory percussion coenzyme q deficiency syndrome,” in VI International Symposium on Biomedical and Clinical Aspects of Coenzyme Q, Eds K. Folkers, G. L. Littarru, and T. Yamagani, Roma, 105, 1990.

Stagnaro-Neri M and Stagnaro S. Acidi grassi W-3, scavengers dei radicali liberi e attivatori del ciclo Q della sintesi del Co Q10. Gazz Med It Arch Sci Med 1992; 151: 341.

Stagnaro-Neri and M, Stagnaro S. Semeiotica Biofisica: la manovra di Ferrero- Marigo nella diagnosi clinica della iperinsulinemia-insulinoresistenza. Acta Med Medit 1997; 13: 125.

Vereczkei A , Mirnics K. Genetic predisposition to schizophrenia: what did we learn and what does the future hold? Neuropsychopharmacol Hung 2011; 13(4): 205-210.

Vetter MW, Martin BJ, Fung M, Pajevic M, Anderson TJ, Raedler TJ. Microvascular dysfunction in schizophrenia: a case–control study. Schizophrenia 2015; 15023.

Zhao G, Denisova K, Sehatpour P, Long J, Gui W, Qiao J, Javitt DC, Wang Z. Fractal Dimension Analysis of Subcortical Gray Matter Structures in Schizophrenia. PLoS One 2016; 13;11(5): e0155415.


Supporting Agencies





| NeuroScience + QuantumPhysics> NeuroQuantology :: Copyright 2001-2019